Literature DB >> 24956530

Impact of overweight on myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study.

Gwan Hyeop Sohn1, Eun Kyoung Kim1, Joo-Yong Hahn2, Young Bin Song1, Jeong Hoon Yang3, Sung-A Chang4, Sang-Chol Lee4, Yeon Hyeon Choe5, Seung-Hyuk Choi1, Jin-Ho Choi6, Sang Hoon Lee1, Jae K Oh1, Hyeon-Cheol Gwon1.   

Abstract

OBJECTIVE: Although obesity is a risk factor for cardiovascular disease and mortality, several studies have reported that patients with obesity who have suffered acute myocardial infarction or have undergone percutaneous coronary intervention (PCI) have better clinical outcomes than their normal weight counterparts. We evaluated the impact of overweight on myocardial infarct size in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI).
METHODS: We performed contrast-enhanced magnetic resonance imaging on 193 patients undergoing primary PCI for STEMI. Infarct size was measured with delayed-enhancement imaging and the area at risk was quantified on T2-weighted images.
RESULTS: Baseline characteristics and angiographic findings were not significantly different between the normal weight group (body mass index [BMI] < 25 kg/m(2), n = 110) and the overweight group (BMI ≥ 25 kg/m(2), n = 83). The median percent infarct volume and area at risk were significantly smaller in the overweight group than the normal weight group (17.9% [9.0-24.9%] vs. 20.8% [11.4-33.1%], p = 0.04 and 29.4% [20.5-37.6%] vs. 36.0% [25.7-49.6%], p < 0.01, respectively). However, the myocardial salvage index was not different between the 2 groups (overweight group vs. normal weight group, 43.2% vs. 39.2%, p = 0.69). BMI ≥ 25 kg/m(2) was an independent predictor of smaller infarct size in multivariate analysis (Odds ratio 0.51, 95% Confidence interval 0.27-0.97, p = 0.039).
CONCLUSION: Overweight (BMI ≥ 25 kg/m(2)) is independently associated with smaller infarct size in patients undergoing primary PCI for STEMI.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Myocardial infarction; Obesity

Mesh:

Year:  2014        PMID: 24956530     DOI: 10.1016/j.atherosclerosis.2014.05.961

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry.

Authors:  Ki-Bum Won; Seung-Ho Hur; Yun-Kyeong Cho; Hyuck-Jun Yoon; Chang-Wook Nam; Kwon-Bae Kim; Jang-Ho Bae; Dong-Ju Choi; Young-Keun Ahn; Jong-Seon Park; Hyo-Soo Kim; Rak-Kyeong Choi; Donghoon Choi; Joon-Hong Kim; Kyoo-Rok Han; Hun-Sik Park; So-Yeon Choi; Jung-Han Yoon; Hyeon-Cheol Kwon; Seung-Un Rha; Kyung-Kuk Hwang; Do-Sun Lim; Kyung-Tae Jung; Seok-Kyu Oh; Jae-Hwan Lee; Eun-Seok Shin; Kee-Sik Kim
Journal:  Cardiovasc Diabetol       Date:  2015-10-15       Impact factor: 9.951

2.  Prognostic value of the myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement magnetic resonance imaging after ST-segment elevation myocardial infarction: A systematic review and meta-regression analysis.

Authors:  Benjamin Kendziora; Marc Dewey
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

3.  Impact of Obesity on Microvascular Obstruction and Area at Risk in Patients After ST-Segment-Elevation Myocardial Infarction: A Magnetic Resonance Imaging Study.

Authors:  Di-Hui Lan; Yue Zhang; Bing Hua; Jin-Shui Li; Yi He; Hui Chen; Wei-Ping Li; Hong-Wei Li
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-28       Impact factor: 3.249

4.  Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction: A propensity score matching analysis from the Korea Acute Myocardial Infarction Registry.

Authors:  Ki-Bum Won; Seung-Ho Hur; Chang-Wook Nam; Soe Hee Ann; Gyung-Min Park; Sang-Gon Lee; Hyo-Eun Kim; Yun-Kyeong Cho; Hyuck-Jun Yoon; Hyoung-Seob Park; Hyungseop Kim; Seongwook Han; Myung-Ho Jeong; Young-Keun Ahn; Seung-Woon Rha; Chong-Jin Kim; Myeong-Chan Cho; Hyo-Soo Kim; Shung-Chull Chae; Kee-Sik Kim; Young-Jo Kim; Kwon-Bae Kim; Philip Barter
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.